Growth funding Spring Science has secured funding of 22M and operates in the biotech research space with revenue between 1M and 10M, signaling growing sales capacity and potential willingness to invest in technology that accelerates discovery and preclinical work.

Small team leverage With a lean team of 2-10 employees, they likely lean on scalable software solutions and partner-heavy collaborations; sales opportunities exist in easy-to-deploy tools that augment researchers without heavy customization.

Tools for researchers Their tech stack includes collaboration, design, and workflow platforms (Figma, Trello, Framer Sites, Google Workspace) and ML/design capabilities, indicating interest in software that enhances data interpretation, project management, and rapid prototyping.

Disease focus Mission to fight disease and support preclinical efforts suggests opportunities for tools that streamline high-dimensional data analysis, modeling, and decision-support across discovery and translational stages.

Brand and presence Recent website redesign and emphasis on resources and product insights signal a marketing-driven approach; potential success in partnerships or co-marketing initiatives with vendors offering complementary bioscience platforms.